Back to Search Start Over

Bayer: kidney cancer drug offers hope for patients and pipeline.

Source :
PharmaWatch: Monthly Review; December2004, Vol. 3 Issue 12, p6-6, 2/3p
Publication Year :
2004

Abstract

Reports that Bayer AG and Onyx Pharmaceuticals Inc. have announced positive study data for the Bay 43-9006 drug in the treatment of kidney cancer. Evidence of antitumor activity; Goal of obtaining approval for the drug; Observations noted from patients enrolled in the study.

Details

Language :
English
Volume :
3
Issue :
12
Database :
Complementary Index
Journal :
PharmaWatch: Monthly Review
Publication Type :
Report
Accession number :
17642988